BioPlayground

PC

ProtocolCore

Suggested Protocols

探索型MVP
すべてのプロトコル分野

Gene Delivery / Transfection

Source-bound Gene Delivery / Transfection スタータープロトコル

共通の identity・execution・outcome・handoff contract と二つの exact source profile を提供します。Cell・payload・reagent・vessel・scale の値は profile 間で混合せず、CRISPR と Protein Production には typed receipt のみを渡します。

編集可能な開始プロトコル

3 source-bound starter

このプロトコルは何を行いますか？

共通のidentity・control・execution・outcome contract後に一つのexact profileを選び、planned/actual条件、deviation、delivery、viability、downstream handoffを分離して記録します。

対応するdelivery workflow

  • • Common identity, execution, outcome & handoff
  • • Suspension HEK293 · PEI-MAX · antibody plasmid
  • • MDA-MB-231 · Lipofectamine 3000 · 24-well plasmid

適用範囲

二つのexact profile外のcell・payload・reagent・device・format・scaleを推奨または自動補正せず、viral・in-vivo/LNP・germline・clinical/GMP実行と普遍的成功thresholdは対象外です。

PRT-GD-COMMON-001Common identity, execution, outcome & handoff

Gene Delivery identity, source, control, execution, outcome, and typed-handoff foundation

Gene Delivery / Transfection · GD-FAMILY-CONTRACT-1.0

公式ガイド 確認済み
EXACT_SOURCE_PROFILE_REQUIREDMODEL_ROUTE_TOPOLOGY_PAYLOAD_LOCKNO_CROSS_PROFILE_NUMERIC_MIXINGSOURCE_SCALE_ONLY_UNLESS_EXPLICIT_ARITHMETICCONTROL_DISPOSITION_REQUIREDDELIVERY_VIABILITY_AND_OUTCOME_SEPARATETYPED_DOWNSTREAM_HANDOFFNO_UNIVERSAL_ACCEPTANCE_THRESHOLDRESEARCH_USE_ONLY

Cell・payload・exact source profile を先に一致させてください

実行可能な starter は suspension HEK293/PEI-MAX antibody DNA と MDA-MB-231/Lipofectamine 3000 の exact 24-well path の二つだけです。他の cell・reagent・format は自動補正せず、control と実際の execution 値を明示的に記録します。

1

1. LOCK THE BIOLOGICAL MODEL AND PAYLOAD

Record the exact cell identity, source history, passage or adaptation state, topology, payload identity and downstream purpose before selecting a delivery profile.

2

2. SELECT ONE EXACT SOURCE PROFILE

Match route, model, topology, payload, reagent or device, kit or medium, vessel, scale, source revision and locator; any mismatch returns HOLD.

条件: USER REQUIRED — one exact Gene Delivery profile ID or HOLD.
3

3. FREEZE THE SOURCE LEDGER

Preserve each source value separately from derived arithmetic, local qualification inputs and missing fields; never borrow a condition from another profile.

4

4. PREDECLARE READINESS AND CONTROLS

Record source-specific readiness and assign or explicitly omit every control with a reason before execution.

5

5. RECORD PREPARATION AND DELIVERY

Capture planned and actual component identities, amounts, units, order, timing, vessel, exposure and any deviation against the selected source profile.

時間: SOURCE PROFILE REQUIRED
6

6. RECORD RECOVERY AND HANDOFF

Keep recovery conditions and the downstream Protein Production or CRISPR consumer receipt typed and versioned; do not duplicate the downstream recipe.

7

7. SEPARATE DELIVERY AND VIABILITY EVIDENCE

Record delivery readout and viability or morphology as separate observations with sample, control, replicate and time identities.

8

8. RECORD THE DOWNSTREAM BIOLOGICAL OUTCOME

Link expression, editing or another biological outcome without treating it as interchangeable with delivery success.

9

9. ISSUE A FAIL-CLOSED DISPOSITION

Assign READY, CONDITIONAL, REPEAT, REJECT, HOLD or SPECIALIST REVIEW with deviations, uncertainty, allowed claim and immutable evidence links.